Acadia Healthcare (ACHC) saw its stock plummet 5.03% in intraday trading on Wednesday, following significant price target cuts from two major financial institutions. The sharp decline comes as investors react to less optimistic outlooks from Wall Street analysts.

Mizuho Securities lowered its price target for Acadia Healthcare to $32 from $37, while maintaining a Neutral rating on the stock. Similarly, Barclays cut its target price more dramatically to $28 from $35, keeping an Equal-Weight rating. These downward revisions suggest a more cautious stance on the company's near-term prospects.

The reduced price targets from both Mizuho and Barclays indicate growing concerns about Acadia Healthcare's valuation and potential future performance. While the maintained Neutral and Equal-Weight ratings suggest the analysts are not outright bearish, the significant cuts in price targets have clearly spooked investors, leading to the substantial sell-off in the stock.